Tumor Necrosis Factor News and Research

RSS
An ubiquitin-specific peptidase that potentially promote cancer cell necrosis

An ubiquitin-specific peptidase that potentially promote cancer cell necrosis

Studies suggest role for IL-10 in prevention and treatment of neurological disease in newborns

Studies suggest role for IL-10 in prevention and treatment of neurological disease in newborns

Protein IL-10 removes Escherichia coli K1 bacterium from blood and reverses brain damage

Protein IL-10 removes Escherichia coli K1 bacterium from blood and reverses brain damage

Idera reports preliminary results from IMO-3100 Phase 1 clinical trial for autoimmune, inflammatory diseases

Idera reports preliminary results from IMO-3100 Phase 1 clinical trial for autoimmune, inflammatory diseases

Can-Fite BioPharma opens CF101 IND for psoriasis with US FDA

Can-Fite BioPharma opens CF101 IND for psoriasis with US FDA

Narrow-band imaging could be novel tool for in vivo assessment of mucosal angiogenesis

Narrow-band imaging could be novel tool for in vivo assessment of mucosal angiogenesis

Research article focuses on how IECs respond to probiotic strain B. lactis HN019

Research article focuses on how IECs respond to probiotic strain B. lactis HN019

GenVec's 2009 revenues down 8%: MicroStockProfit.com

GenVec's 2009 revenues down 8%: MicroStockProfit.com

Celldex Therapeutics presents CDX-1127 antibody program at AACR Annual Meeting

Celldex Therapeutics presents CDX-1127 antibody program at AACR Annual Meeting

First case of treating cystic fibrosis and Crohn's disease with infliximab

First case of treating cystic fibrosis and Crohn's disease with infliximab

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Infliximab-azathioprine combination helps more Crohn's disease patients achieve remission

Infliximab-azathioprine combination helps more Crohn's disease patients achieve remission

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

Two-drug combination destroys precancerous colon polyps

Two-drug combination destroys precancerous colon polyps

Lung transplant patients may one day benefit from synthetic peptide, researchers report

Lung transplant patients may one day benefit from synthetic peptide, researchers report

Interfering with dickkopf 1 protein may help in controlling inflammatory bowel diseases

Interfering with dickkopf 1 protein may help in controlling inflammatory bowel diseases

Blocking GM-CSF could reduce inflammation and deleterious effects of cigarette smoke exposure

Blocking GM-CSF could reduce inflammation and deleterious effects of cigarette smoke exposure

Genentech submits ACTEMRA sBLA to FDA

Genentech submits ACTEMRA sBLA to FDA

MIF exhibits potential as viable therapeutic target for Type 2 diabetes

MIF exhibits potential as viable therapeutic target for Type 2 diabetes

StockPreacher.com announces investment report featuring GenVec

StockPreacher.com announces investment report featuring GenVec